9/9/2025China's NMPA Seeks Public Feedback on Draft Guidelines for Online Pres...

9/9/2025China's PD-(L)1 Market Shows Continued Growth in H1 2025, Domestic Bra...

9/9/2025RemeGen's Telitacicept Advances in Sjögren's Syndrome

9/9/2025BioNTech and BMS Report Promising Global Phase II Data for Pumitamig

9/8/2025NHSA Seeks Feedback on Draft Implementation Rules for Medical Insuranc...

9/8/2025CDE Opens Public Consultation on Draft Guidelines for Clinical Trials ...

9/8/2025CDE Invites Feedback on Draft Guidelines for Clinical Trials of Target...

9/8/2025CDE Seeks Comments on Draft Guidelines for Clinical Trials of Anti-Fib...

9/8/2025CDE Solicits Comments on Draft Guidelines for Type I Meetings on Advan...

9/8/2025CDE Opens Public Consultation on Draft Guidelines for Type I Meetings ...

9/8/2025CDE Seeks Comments on Draft Technical Guidelines for Chemically Synthe...

9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...

9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...

9/8/2025CDE Issues Technical Guidelines for Clinical Pharmacology Research on ...

9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...

9/8/2025Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...

9/8/2025Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...

9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...

9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...

9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...

9/8/2025Epigenic Secures $60M in Series B Financing to Advance Epigenetic Drug...

9/5/2025Hengrui Licenses Myosin Inhibitor HRS-1893 to U.S. Startup Braveheart ...

9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval

9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102

9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...

9/4/2025CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development

9/4/2025iRegene Raises Series B+ to Advance Parkinson's and Ophthalmology Cell...

9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...

9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...

9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...

Page:10/59 Total number of articles:1744: [First][<<] [8] [9] [10] [11] [12] [>>] [End]